The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of adrenergic and prostanoid inhibitors on outcomes in patients with advanced hepatocellular carcinoma (HCC): A prospective clinical trial.
Gouri Shankar Bhattacharyya
Consultant or Advisory Role - Vicus Therapeutics
Shailesh Arjun Bondarde
No relevant relationships to disclose
Ghanashyam Biswas
No relevant relationships to disclose
K Govind Babu
No relevant relationships to disclose
Debasis Dutta
No relevant relationships to disclose
Newell F. Bascomb
Employment or Leadership Position - Vicus Therapeutics
Stock Ownership - Vicus Therapeutics
Hemant Malhotra
No relevant relationships to disclose